Background: The association of vaginal laxity with female sexual function is clinically significant. Male sexual pleasure can also be affected by vaginal laxity. Objectives: The aim of this study was to investigate the effect of vaginoplasty on a cohort of women who underwent this procedure for indications of vaginal laxity/impaired sexual function. The sexual satisfaction of partners after vaginal tightening was also evaluated. Methods: Fifty women who underwent vaginoplasty and their male partners (n = 50) were included in the study. The State-Trait Anxiety Inventory (STAI) and the Female Sexual Function Index (FSFI) were administered to female patients 3 months before and after the treatment. In addition, the sexual function of male partners was assessed by the International Index of Erectile Function-5 (IIEF-5) 3 months before and after the treatment. A 5-question questionnaire inquiring about pleasure status, scored on a 4-point Likert scale, was administered to the male partners. Results: The posttreatment STAI-State and STAI-Trait scores of the female patients were statistically significantly lower than their pretreatment scores (52.5 vs 32, P < .001; 56 vs 44, P < .001, respectively). The posttreatment FSFI score of the female patients was significantly higher than their pretreatment score (19.2 vs 29.7, P < .001). Conclusions: The results demonstrated a significant improvement in the sexual function of males and females, and additionally, a significant decrease in the indices of temporary anxiety levels and the inherent predisposition for anxiety disorders after vaginoplasty. Level of Evidence: 4:

Amaç: Bu çalışmanın arka planı, labia majoraplasti tekniğimiz ve komplikasyonları ile ilgili deneyimlerimizi ve cerrahi sonuçlarımızı paylaşmaktır. Gereç ve Yöntem: Çalışmaya labium majus sarkması, yağ dokusunda azalma, ciltte aşırı kırışıklık ve katlanma şikayeti ile başvuran 63 hasta dahil edildi. İşlem sonrası labia majoranın görünümü fotoğraflarla ve kadın genital benlik imajı ölçeğini (FGSIS) içeren hasta memnuniyet anketleriyle değerlendirildi. Bulgular: İşlemden sonra hayatı tehdit eden herhangi bir komplikasyon veya ciddi sekeller görülmedi. Dolayısıyla, daha yüksek FGSIS puanı daha olumlu bir genital benlik imajına işaret ettiğinden ve kadının cinsel işlevi, cinsel davranışı ve cinsel davranışı ile önemli ölçüde ilişkili olduğundan, ameliyat sonrası genital güzellik açısından daha iyi sonuçlar elde edildi. cinsel ve genital sağlık bakım davranışları. 6 aylık takipte ortalama toplam FGSIS skoru ameliyat öncesi 20,4 ± 1,2 ve ameliyat sonrası 22,4 ± 1,4 olup istatistiksel olarak anlamlı bir farka işaret etmektedir (p = 0,026) Sonuç: İç dudak estetiği, fonksiyonlara, hijyene ve estetik görünüme olumlu katkı sağlayan bir cerrahi işlemdir. Mevcut cerrahi teknikte yaşamı tehdit eden kalıcı sekel bırakan majör komplikasyonların görülmemesi ve minör komplikasyonların kısa sürede kontrol altına alınabilmesi bu çalışmada uygulanan tekniğin rahatlıkla uygulanabilir olduğunu göstermektedir. Aynı zamanda FGSIS sonuçlarında da olumlu yönde anlamlı bir iyileşme gözlendi ve hastalarda özgüven artışıyla ilişkilendirildi.

Aims: The aim of this study is to share our experiences and results with our intravaginal gas ozone technique in the treatment of bacterial vaginosis (BV) by retrospective data analysis. Methods: Salutem plus brand medical ozone device, 60 gamma 200 cc gas ozone was administered intravaginally through 50 cc syringes with the help of a nasogastric catheter to 102 patients diagnosed with BV using Amsel criteria. Patients whose hemogram parameters were checked before and after the procedure were called for 1st, 3rd, 6th, 9th and 12th month clinical controls in terms of recurrence, and the examination findings and digital data of these patients were analyzed retrospectively in terms of treatment, complications and recurrence. Results: No life-threatening complications were encountered. Minor adverse effects were observed and resolved spontaneously in a short time without the need for any treatment. Recurrence rates were observed to be lower than in classical regimen treatments. Additionally, no more than 2 recurrences were observed during 1-year follow-up. Conclusion: Our study is the first example of the literature in terms of evaluation of treatment, recurrence and complications of intravaginal gas ozone therapy in the treatment of bacterial vaginosis. These finding suggest that intravaginal gas ozone therapy, which is considered a safe form of treatment, will become more widespread in the future and the number and frequency of its application will increase even more. Further investigation with a larger number of patients should be conducted to confirm our data.

Background: This study aimed to explore the relationship between acetabular dysplasia (AD), a known risk factor for pelvic floor dysfunction (PFD), and its effects on sexual function and psychological well-being in women. Methods: A cross-sectional study was conducted with 125 female patients experiencing genitopelvic pain and penetrative disorders. Participants were categorized into AD-positive and AD-negative groups based on anteroposterior pelvic radiographs. Sexual function was evaluated using the Golombok–Rust Sexual Satisfaction Inventory (GRISS), while pain and psychological well-being were assessed using the Visual Analog Scale (VAS) and the Beck Depression Inventory (BDI), respectively. Results: Results showed that AD-positive patients had significantly higher pain (VAS: 8.15 ± 1.1, p < 0.001) and anxiety scores (BDI: 12.3 ± 11.0, p < 0.02). Sexual function was notably impaired in the AD-positive group, with lower sexual satisfaction and a higher prevalence of anorgasmia (p = 0.01). The AD-negative group demonstrated better scores in frequency and satisfaction with touch (p = 0.04, p = 0.03). Additionally, AD-positive patients exhibited limited hip rotation and a higher incidence of osteoarthritis and Legg–Calvé–Perthes disease. Conclusions: This study highlights the broader impact of AD on women’s quality of life, emphasizing the need for targeted therapeutic interventions to address sexual dysfunction and psychological distress in affected patients.

OBJECTIVE: To investigate the effect of relaxation of vaginal muscles with EMG measurements after transmucosal electrical nerve stimulation (TENS) application. We planned to implement a method that would allow our treatment success data to be easily collected and analyzed with instant digital EMG data. MATERIAL and METHODS: This study was conducted at our private clinic of between January 2022 and October 2024. The intravaginal device of the NeuroTrac MyoPlus2 Pro device (Verity Medical Ltd, Ireland) was placed into the vagina in an average of 30–45 seconds. Then, electromyography (EMG) measurements of voluntary contraction and relaxation were taken in the work and rest assessment mode, 5 seconds of contraction and 5 seconds of relaxation for 55 seconds. Then, intravaginal TENS was applied with the intravaginal apparatus in the current relaxation mode recorded in the device at 30 mA power for 20 minutes Then, EMG measurements of contraction and relaxation were taken during 5 seconds of voluntary contraction and 5 seconds of relaxation, for a total of 55 seconds. RESULTS: 135 patients who underwent intravaginal device of the NeuroTrac MyoPlus2 Pro for vaginismus were included in this study. At work, average and lowest EMG values were significantly lower after therapy (22.8 vs 17.8 mV, p=0.013; 9.8 vs 8.1 mV, p<0.001, respectively). Highest EMG value and maximum voluntary contraction (MVC) value were similar before and after therapy. At rest, average, lowest, highest and MVC values were statistically significantly higher after therapy (3.8 vs 1.9 mV; 1.2 vs 0.6 mV; 13.8 vs 10.3 mV and 16% vs 13%, p<0.001, respectively). CONCLUSION: The NeuroTrac MyoPlus2 Pro intravaginal device can be applied as an effective treatment modality in the management of vaginismus. Keywords: electromyography, intravaginal device, transmucosal electrical nerve stimulation, vaginismus